Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available

MeSH terms

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols* / adverse effects
• Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
• Female
• Humans
• Leukemia, Myeloid, Acute* / diagnosis
• Leukemia, Myeloid, Acute* / drug therapy
• Leukemia, Myeloid, Acute* / genetics
• Leukemia, Myeloid, Acute* / mortality
• Male
• Middle Aged
• Mutation
• Nuclear Proteins* / genetics
• Nucleophosmin*
• Prognosis
• Treatment Outcome